| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/10/2013 | WO2012158964A3 Improved peptide pharmaceuticals for osteoporosis |
| 01/10/2013 | WO2012121988A3 Methods for treating diseases using isoindoline compounds |
| 01/10/2013 | US20130012585 Phenylacetic Acid Derivatives |
| 01/10/2013 | US20130012583 Vinyl substituted fatty acids |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012553 Methods for stabilizing joint damage in subjects using xanthine oxidoreductase inhibitors |
| 01/10/2013 | US20130012545 Amido-Thiophene Compounds and Their Use |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130012526 Oxazole derivatives useful as modulators of faah |
| 01/10/2013 | US20130012518 Bicyclic compounds and their uses as dual c-src / jak inhibitors |
| 01/10/2013 | US20130012510 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1 |
| 01/10/2013 | US20130012505 Benzonaphthyridinamines as autotaxin inhibitors |
| 01/10/2013 | US20130012499 Trpv4 antagonists |
| 01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 01/10/2013 | US20130012486 Combination steroid and glucocorticoid receptor antagonist therapy |
| 01/10/2013 | US20130012485 Organic compounds |
| 01/10/2013 | US20130012479 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012475 Cosmetic and Pharmaceutical Composition Comprising N-Acetylglucosamine-6-Phosphate |
| 01/10/2013 | US20130012466 Colchicine neoglycosides and methods for their synthesis and use |
| 01/10/2013 | US20130012463 Identification of free-b-ring flavonoids as potent cox-2 inhibitors |
| 01/10/2013 | US20130012445 Compositions for Improving Bone Mass |
| 01/10/2013 | US20130012440 Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans |
| 01/10/2013 | US20130012432 Peptides for Treatment of Obesity |
| 01/10/2013 | US20130012427 Polypeptides |
| 01/10/2013 | US20130011498 Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate |
| 01/10/2013 | US20130011482 Dual component medicament delivery system |
| 01/10/2013 | US20130011475 Stable compositions of famotidine and ibuprofen |
| 01/10/2013 | US20130011463 Method and device for synovial cell-charged collagen membrane or gel |
| 01/10/2013 | US20130011453 Buffered microencapsulated compositions and methods |
| 01/10/2013 | US20130011446 Ceramic composition for filling bone defects |
| 01/10/2013 | US20130011442 Method for repair of articular cartilage defect and a device used therein |
| 01/10/2013 | US20130011441 TARGETED DELIVERY OF siRNA |
| 01/10/2013 | US20130011416 Injectable solution containing therapeutic agent for osteoarthritis |
| 01/10/2013 | US20130011407 Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
| 01/10/2013 | US20130011405 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 01/10/2013 | US20130011401 Soluble proteins for use as therapeutics |
| 01/10/2013 | US20130011398 Serpin Fusion Polypeptides and Methods of Use Thereof |
| 01/10/2013 | US20130011391 Anti-psgl-1 antibodies and uses thereof |
| 01/10/2013 | US20130011361 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 01/10/2013 | CA2840895A1 Composition for maintaining bone health and for treating osteoarthritis and osteoarthrosis of the joints |
| 01/10/2013 | CA2839341A1 Methods of treating or preventing rheumatic disease |
| 01/09/2013 | EP2543374A2 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 01/09/2013 | EP2542540A1 Polymorph of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid |
| 01/09/2013 | EP2542539A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 01/09/2013 | EP2542263A2 Ep1 inhibition |
| 01/09/2013 | EP2542080A1 Treatment of lupus arthritis using laquinimod |
| 01/09/2013 | EP2542079A1 Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate |
| 01/09/2013 | CN202653713U Medicine pad |
| 01/09/2013 | CN102869658A Modulators of fatty acid amide hydrolase |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102863531A CD20-resistant monoclonal antibody as well as preparation method and application thereof |
| 01/09/2013 | CN102863350A Anti-inflammatory analgesia mutual prodrug of non-steroidal antiinflammatory drug and preparation method thereof |
| 01/09/2013 | CN102861340A Intelligent nano delivery system, preparation method and application thereof |
| 01/09/2013 | CN102861335A DHEA compositions for treating menopause |
| 01/09/2013 | CN102861331A CD (cluster differentiation) 146 and application thereof to antibody diagnosis and treatment for inflammable diseases such as autoimmunity diseases |
| 01/09/2013 | CN102861312A Plaster for treating osteoarthritis and phymatosis |
| 01/09/2013 | CN102861307A Group of wild ginger pain-relieving combined tablets |
| 01/09/2013 | CN102861296A Pill inducing diuresis and reducing edema for treating gonarthromeningitis |
| 01/09/2013 | CN102861270A Muscular and bone pain relieving medicinal liquor for treating ankylosing spondylitis |
| 01/09/2013 | CN102861268A Traditional Chinese medicine for treating rheumatoid arthritis |
| 01/09/2013 | CN102861264A Traditional Chinese medicine for treating gout |
| 01/09/2013 | CN102861245A Medicine for preventing and treating gout disease |
| 01/09/2013 | CN102861203A Method for preparing medicines for treating cervical vertebra pain |
| 01/09/2013 | CN102861196A Traditional Chinese medicine for setting bones |
| 01/09/2013 | CN102861195A Drug composition for treating rheumatism pain |
| 01/09/2013 | CN102861165A Traditional Chinese medicine preparation for treating lupus erythematosus |
| 01/09/2013 | CN102861144A Traditional Chinese medicine for treating cervical spondylosis |
| 01/09/2013 | CN102861143A Chinese medicine formula for curing gout |
| 01/09/2013 | CN102861123A Traditional Chinese medicine extract with effect on promoting angiogenesis as well as preparation method and application thereof |
| 01/09/2013 | CN102861044A Novel application of himalayan teasel root chemical compositions |
| 01/09/2013 | CN102861033A Application of Gypensapogenin A in medicine for treating acute gout |
| 01/09/2013 | CN102861032A Application of Gypensapogenin A in medicine for treating rheumatoid arthritis |
| 01/09/2013 | CN102861030A Application of Gypensapogenin B in medicine for treating acute gout |
| 01/09/2013 | CN102860991A Medicine composition containing febuxostat and preparation method thereof |
| 01/09/2013 | CN102233112B Pharmaceutical composition for treatment of lumbar disc herniation and preparation method thereof |
| 01/09/2013 | CN102228594B Oxalis corymbosa and white flower tablet |
| 01/09/2013 | CN102151255B Application of resveratrol in preparing medicines for preventing and treating radiation-induced bone marrow suppression |
| 01/09/2013 | CN102106831B 地西他滨冻干制剂及其制备方法 Decitabine lyophilized formulation and preparation method |
| 01/09/2013 | CN102040643B Ciclesonide nitrate derivative |
| 01/09/2013 | CN101935349B Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/09/2013 | CN101824424B DNA vaccine based on B7-2-PE40 exotoxin fusion gene and application thereof |
| 01/09/2013 | CN101822645B Controlled-release recombinant human bone morphogenic protein-2 poly-L-lactic acid microspheres and preparation method thereof |
| 01/09/2013 | CN101781353B 20(S)-ginsenoside Rh2 derivatives for regulating and controlling ER Alpha/ER Beta-TNF Alpha channel as well as preparation and anti-tumor application thereof |
| 01/09/2013 | CN101636411B Interferon alpha 2a modified by polyethylene glycol, synthesis process and application thereof |
| 01/09/2013 | CN101223158B N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 01/08/2013 | US8350016 Oligonucleotide compositions and their use to induce apoptosis |
| 01/08/2013 | US8349896 Aspirin-triggered lipid mediators |
| 01/08/2013 | US8349816 Antibacterial treatment of osteoarthritis |
| 01/08/2013 | US8349012 Intervertebral disc treatment devices and methods |
| 01/08/2013 | CA2690001C Substituted benzoylamino-indan-2-carboxylic acids and related compounds |
| 01/08/2013 | CA2559188C Hyaluronic acid-methotrexate conjugate |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/08/2013 | CA2495395C Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2385498C Method to enhance healing of sternum after sternotomy |
| 01/03/2013 | WO2013003697A1 Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
| 01/03/2013 | WO2013003641A2 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | WO2013002313A1 Weight control drug |
| 01/03/2013 | WO2013002248A1 Phosphoric acid ester derivative |
| 01/03/2013 | WO2013001819A1 SOLUBLE INTEGRIN α4 MUTANT |